Ascites samples from women undergoing surgery for ovarian cancer will be collected for use in translational research.
All female participants, regardless of ethnicity, who are undergoing cytoreductive surgery for ovarian cancer are eligible for this study
All participants will be eighteen years old or older
Patients must be suspected of having a pathological diagnosis or clinical suspicion of ovarian cancer and be scheduled for surgery for tumor resection.
Ability to understand and the willingness to sign a written informed consent document.
We do not intend to include participants if they are unable to provide informed consent for this study themselves (e.g. mentally ill patients who require health care proxies to consent for any medical intervention), or vulnerable populations such as prisoners.
Minors under age eighteen.
Pregnant women.
Final pathologic diagnosis that does not confirm invasive epithelial ovarian, tubal, or primary peritoneal cancer
All female participants, regardless of ethnicity, who are undergoing cytoreductive surgery for ovarian cancer are eligible for this study; All participants will be eighteen years old or older; Patients must be suspected of having a pathological diagnosis or clinical suspicion of ovarian cancer and be scheduled for surgery for tumor resection.
Other
Prospective
Not listed
Collect ascites fluid obtained from ovarian cancer patients during cytoreductive surgery or paracentesis
To elucidate the conditions of the tumor environment that contribute to cancer dissemination in the peritoneal cavity through ex vivo evaluation of malignant ascites collected from women with ovarian, tubal, or primary peritoneal cancer.
To correlate specific features of peritoneal cell populations or soluble factors with patient outcome.
To correlate specific features of peritoneal cell populations or soluble factors with patient outcome.
Click on the lead sponsor to view all of their trials.
